Intended for healthcare professionals

  1. Research
  2. Clopidogrel plus...
  3. Clopidogrel plus aspirin versus aspirin alone for acute minor ischaemic stroke or high risk transient ischaemic attack: systematic review and meta-analysis
CCBYNC Open access
Research

Clopidogrel plus aspirin versus aspirin alone for acute minor ischaemic stroke or high risk transient ischaemic attack: systematic review and meta-analysis

BMJ 2018; 363 doi: https://doi.org/10.1136/bmj.k5108 (Published 18 December 2018) Cite this as: BMJ 2018;363:k5108

Linked practice

Dual antiplatelet therapy with aspirin and clopidogrel for acute high risk transient ischaemic attack and minor ischaemic stroke

Data supplement

  • Web extra

    • Data Supplement - Supplementary appendix 1: Search strategies and results
    • Data Supplement - Supplementary appendix 2: Forest plots and sensitivity analysis
    • Data Supplement - Supplementary appendix 3: Definition of bleeding events and stroke subtypes in the three included trials
    • Data Supplement - Supplementary appendix 4: Adequate duration of therapy with dual antiplatelet therapy

Related articles

PracticeDual antiplatelet therapy with aspirin and clopidogrel for acute high risk transient ischaemic attack and minor ischaemic stroke

See more

Cited by...

  • Optimal duration of dual antiplatelet therapy for minor stroke within 72 hours of symptom onset: a prospective cohort study
  • Beyond COVID-19: respiratory infection and cardiovascular events
  • Single or dual antiplatelet therapy after a transient ischaemic attack or minor ischaemic stroke?
  • Antithrombotic Therapy to Prevent Recurrent Strokes in Ischemic Cerebrovascular Disease: JACC Scientific Expert Panel
  • Acute dual antiplatelet therapy for minor ischaemic stroke or transient ischaemic attack
  • Dual antiplatelet therapy with aspirin and clopidogrel for acute high risk transient ischaemic attack and minor ischaemic stroke: a clinical practice guideline
Back to top